BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30858631)

  • 1. Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up.
    Pawlak-Buś K; Schmidt W; Olejarz M; Czyż A; Komarnicki M; Leszczyński P
    Reumatologia; 2019; 57(1):50-54. PubMed ID: 30858631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
    Milanetti F; Bucha J; Testori A; Burt RK
    Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
    Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
    Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis.
    Burt RK; Oliveira MC; Shah SJ; Moraes DA; Simoes B; Gheorghiade M; Schroeder J; Ruderman E; Farge D; Chai ZJ; Marjanovic Z; Jain S; Morgan A; Milanetti F; Han X; Jovanovic B; Helenowski IB; Voltarelli J
    Lancet; 2013 Mar; 381(9872):1116-24. PubMed ID: 23363664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
    Burt RK; Milanetti F
    Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
    van Laar JM; Farge D; Sont JK; Naraghi K; Marjanovic Z; Larghero J; Schuerwegh AJ; Marijt EW; Vonk MC; Schattenberg AV; Matucci-Cerinic M; Voskuyl AE; van de Loosdrecht AA; Daikeler T; Kötter I; Schmalzing M; Martin T; Lioure B; Weiner SM; Kreuter A; Deligny C; Durand JM; Emery P; Machold KP; Sarrot-Reynauld F; Warnatz K; Adoue DF; Constans J; Tony HP; Del Papa N; Fassas A; Himsel A; Launay D; Lo Monaco A; Philippe P; Quéré I; Rich É; Westhovens R; Griffiths B; Saccardi R; van den Hoogen FH; Fibbe WE; Socié G; Gratwohl A; Tyndall A;
    JAMA; 2014 Jun; 311(24):2490-8. PubMed ID: 25058083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
    Rebeiro P; Moore J
    Intern Med J; 2016 Jan; 46(1):17-28. PubMed ID: 26524106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
    Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
    Front Immunol; 2018; 9():2390. PubMed ID: 30386340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell transplant in systemic sclerosis: An Indian experience.
    Nair V; Vasdev V; Kumar A; Shankar S; Nair V; Sharma A
    Int J Rheum Dis; 2018 Apr; 21(4):859-865. PubMed ID: 29392863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation for systemic sclerosis.
    Farge D; Nash R; Laar JM
    Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol.
    Spierings J; van Rhenen A; Welsing PM; Marijnissen AC; De Langhe E; Del Papa N; Dierickx D; Gheorghe KR; Henes J; Hesselstrand R; Kerre T; Ljungman P; van de Loosdrecht AA; Marijt EW; Mayer M; Schmalzing M; Schroers R; Smith V; Voll RE; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Walker UA; Wuttge DM; van Laar JM
    BMJ Open; 2021 Mar; 11(3):e044483. PubMed ID: 33737437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy.
    Nakamura H; Odani T; Yasuda S; Noguchi A; Fujieda Y; Kato M; Oku K; Bohgaki T; Sugita J; Endo T; Teshima T; Atsumi T
    Mod Rheumatol; 2018 Sep; 28(5):879-884. PubMed ID: 29251023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
    Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on stem cell transplantation for systemic sclerosis: recent trial results.
    Naraghi K; van Laar JM
    Curr Rheumatol Rep; 2013 May; 15(5):326. PubMed ID: 23516015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis.
    Martini A; Maccario R; Ravelli A; Montagna D; De Benedetti F; Bonetti F; Viola S; Zecca M; Perotti C; Locatelli F
    Arthritis Rheum; 1999 Apr; 42(4):807-11. PubMed ID: 10211898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
    Burt RK; Traynor A; Statkute L; Barr WG; Rosa R; Schroeder J; Verda L; Krosnjar N; Quigley K; Yaung K; Villa Bs M; Takahashi M; Jovanovic B; Oyama Y
    JAMA; 2006 Feb; 295(5):527-35. PubMed ID: 16449618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.
    Oyama Y; Barr WG; Statkute L; Corbridge T; Gonda EA; Jovanovic B; Testori A; Burt RK
    Bone Marrow Transplant; 2007 Sep; 40(6):549-55. PubMed ID: 17646844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematopoietic stem cell transplantation in systemic sclerosis.
    Walker UA; Saketkoo LA; Distler O
    RMD Open; 2018; 4(1):e000533. PubMed ID: 30018796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.